XARVANU Trademark

Trademark Overview

On Monday, February 11, 2013, a trademark application was filed for XARVANU with the United States Patent and Trademark Office. The USPTO has given the XARVANU trademark a serial number of 85846297. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 9, 2017. This trademark is owned by Novartis AG. The XARVANU trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system and the genitourinary system; Pharmaceutical preparations for human use for the treatment of inflammatory disorders; Pharmaceutical preparations for human use for use in dermatology, hematology and oncology; Pharmaceutical preparations for human use for use in transplantation; Pharmaceutical preparations for human use for use in ophthalmology; Pharmaceutical preparations for human use for use in the gastroenterological areas and for the prevention and treatment of ocular disorders or diseases; Pharmaceutical preparations for human use, namely, anti-infectives; pharmaceutical preparations for treating bacterial-based diseases; Pharmaceutical preparations for human use, namely, antivirals, antibiotics and antifungals
xarvanu

General Information

Serial Number85846297
Word MarkXARVANU
Filing DateMonday, February 11, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 9, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 8, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system and the genitourinary system; Pharmaceutical preparations for human use for the treatment of inflammatory disorders; Pharmaceutical preparations for human use for use in dermatology, hematology and oncology; Pharmaceutical preparations for human use for use in transplantation; Pharmaceutical preparations for human use for use in ophthalmology; Pharmaceutical preparations for human use for use in the gastroenterological areas and for the prevention and treatment of ocular disorders or diseases; Pharmaceutical preparations for human use, namely, anti-infectives; pharmaceutical preparations for treating bacterial-based diseases; Pharmaceutical preparations for human use, namely, antivirals, antibiotics and antifungals
Translation of Words in MarkThe wording "XARVANU" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 15, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Tuesday, October 10, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 9, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 6, 2017EXTENSION 5 GRANTED
Tuesday, February 28, 2017EXTENSION 5 FILED
Tuesday, February 28, 2017TEAS EXTENSION RECEIVED
Saturday, September 17, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 16, 2016EXTENSION 4 GRANTED
Wednesday, August 31, 2016EXTENSION 4 FILED
Wednesday, August 31, 2016TEAS EXTENSION RECEIVED
Wednesday, March 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 29, 2016EXTENSION 3 GRANTED
Monday, February 29, 2016EXTENSION 3 FILED
Monday, February 29, 2016TEAS EXTENSION RECEIVED
Thursday, September 10, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 9, 2015EXTENSION 2 GRANTED
Thursday, August 27, 2015EXTENSION 2 FILED
Saturday, September 5, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 27, 2015TEAS EXTENSION RECEIVED
Tuesday, March 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 27, 2015EXTENSION 1 GRANTED
Friday, February 27, 2015EXTENSION 1 FILED
Friday, February 27, 2015TEAS EXTENSION RECEIVED
Tuesday, September 2, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 8, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 8, 2014PUBLISHED FOR OPPOSITION
Wednesday, June 18, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 2, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, May 31, 2014ASSIGNED TO LIE
Monday, May 19, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 17, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, May 17, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 17, 2014TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, November 25, 2013NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, November 25, 2013FINAL REFUSAL E-MAILED
Monday, November 25, 2013FINAL REFUSAL WRITTEN
Tuesday, November 19, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 19, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 19, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 23, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 23, 2013NON-FINAL ACTION E-MAILED
Thursday, May 23, 2013NON-FINAL ACTION WRITTEN
Tuesday, May 21, 2013ASSIGNED TO EXAMINER
Friday, February 15, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 14, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

xarvanu pharmaceutical preparations human system disorders treatment prevention namely diseases anti